Sandler HM - Search Results

1

Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancer.

Zumsteg ZS, Zelefsky MJ, Woo KM, Spratt DE, Kollmeier MA, McBride S, Pei X, Sandler HM, Zhang Z. Zumsteg ZS, et al. Among authors: sandler hm. BJU Int. 2017 Nov;120(5B):E87-E95. doi: 10.1111/bju.13903. Epub 2017 Jun 3. BJU Int. 2017. PMID: 28464446 Free article.

2

Results of 3D conformal radiotherapy in the treatment of localized prostate cancer.

Fukunaga-Johnson N, Sandler HM, McLaughlin PW, Strawderman MS, Grijalva KH, Kish KE, Lichter AS. Fukunaga-Johnson N, et al. Among authors: sandler hm. Int J Radiat Oncol Biol Phys. 1997 May 1;38(2):311-7. doi: 10.1016/s0360-3016(97)82499-6. Int J Radiat Oncol Biol Phys. 1997. PMID: 9226317

3

Prostate cancer: patient's dilemma?

Sandler HM. Sandler HM. Cancer J Sci Am. 1998 Nov-Dec;4(6):347-8. Cancer J Sci Am. 1998. PMID: 9853131 No abstract available.

4

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.

Shipley WU, Thames HD, Sandler HM, Hanks GE, Zietman AL, Perez CA, Kuban DA, Hancock SL, Smith CD. Shipley WU, et al. Among authors: sandler hm. JAMA. 1999 May 5;281(17):1598-604. doi: 10.1001/jama.281.17.1598. JAMA. 1999. PMID: 10235152

5

Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy.

Sandler HM, Dunn RL, McLaughlin PW, Hayman JA, Sullivan MA, Taylor JM. Sandler HM, et al. Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):629-33. doi: 10.1016/s0360-3016(00)00717-3. Int J Radiat Oncol Biol Phys. 2000. PMID: 11020557

6

Definitions of biochemical failure in prostate cancer following radiation therapy.

Taylor JM, Griffith KA, Sandler HM. Taylor JM, et al. Among authors: sandler hm. Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1212-9. doi: 10.1016/s0360-3016(01)01571-1. Int J Radiat Oncol Biol Phys. 2001. PMID: 11483331

7

High-risk prostate cancer: how high is high?

Sandler HM. Sandler HM. Cancer J. 2002 Jul-Aug;8(4):301-2. doi: 10.1097/00130404-200207000-00005. Cancer J. 2002. PMID: 12184407 No abstract available.

8

Serum prostate-specific antigen and survival after external beam radiotherapy for carcinoma of the prostate.

Roach M 3rd, Weinberg V, McLaughlin PW, Grossfeld G, Sandler HM. Roach M 3rd, et al. Among authors: sandler hm. Urology. 2003 Apr;61(4):730-5. doi: 10.1016/s0090-4295(02)02425-1. Urology. 2003. PMID: 12670556

9

Chemotherapy for localized, high-risk prostate cancer.

Narayan S, Smith DC, Sandler HM. Narayan S, et al. Among authors: sandler hm. Semin Radiat Oncol. 2003 Apr;13(2):152-7. doi: 10.1053/srao.2003.50012. Semin Radiat Oncol. 2003. PMID: 12728444 Review.

10

Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy.

Tsien C, Griffith KA, Sandler HM, McLaughlin P, Sanda MG, Montie J, Reddy S, Hayman JA. Tsien C, et al. Among authors: sandler hm. Urology. 2003 Jul;62(1):93-8. doi: 10.1016/s0090-4295(03)00127-4. Urology. 2003. PMID: 12837430

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters